CLA-2-29:S:N:N7:239 810660
James J. Lagrosa
Merck & Company, Inc.
One Merck Drive
P.O. Box 100
Whitehouse Station, NJ 08889-0100
RE: The tariff classification of 2-Butyl-5-Chloro-1H-Imidazole-
4-Carbaldehyde from France.
Dear Mr. Lagrosa:
In your letter dated May 3, 1995 you requested a tariff
classification ruling for 2-butyl-5-chloro-1H-imidazole-4-
carbaldehyde which you have stated is a late stage intermediate
chemical used in the production of the pharmaceutical active,
losartan potassium.
The applicable subheading will be 2933.29.9000, Harmonized
Tariff Schedule of the United States (HTS), which provides for
heterocyclic compounds with nitrogen hetero-atom(s) only; nucleic
acids and their salts (con.): compounds containing an unfused
imidazole ring (whether or not hydrogenated) in the structure:
other. The rate of duty will be 7.6 percent ad valorem.
This ruling is being issued under the provisions of Section
177 of the Customs Regulations (19 C.F.R. 177).
A copy of this ruling letter should be attached to the entry
documents filed at the time this merchandise is imported. If the
documents have been filed without a copy, this ruling should be
brought to the attention of the Customs officer handling the
transaction.
Sincerely,
Jean F. Maguire
Area Director
New York Seaport